Revolutionizing Blood Pressure Monitoring: Introducing CART-BP Pro's Game-Changing Accuracy

In a groundbreaking advancement set to redefine hypertension management, Bio-Signal Platform (BSP) Inc., a pioneering spin-off from DGIST, has unveiled its revolutionary device: CART-BP Pro. This innovative blood pressure monitor stands poised to disrupt the status quo, offering unprecedented accuracy that remains uncompromised by arm position, a limitation that has plagued traditional blood pressure monitoring for decades.

For too long, the efficacy of at-home blood pressure readings has been contingent on a crucial, often overlooked, detail: maintaining the cuff at heart level.

Any deviation could lead to skewed results, potentially misguiding individuals and healthcare providers in managing a condition affecting billions worldwide. CART-BP Pro shatters this constraint, ushering in a new era where accurate blood pressure measurement is truly accessible and convenient, regardless of how or where the arm is positioned.

At the heart of CART-BP Pro's remarkable capabilities lies its proprietary CARP (Cuff-less ARm Position-independent) technology.

This cutting-edge innovation, coupled with the advanced CART (Cuff-less All-day Real-time Tracking) technology, enables the device to deliver precise readings continuously throughout the day. This isn't just about convenience; it's about providing a holistic, real-time understanding of an individual's blood pressure fluctuations, offering insights that traditional sporadic measurements simply cannot.

The validation of CART-BP Pro's superior performance comes from rigorous clinical trials.

A pivotal study conducted at Seoul National University Hospital (SNUH) pitted the device against the gold standard: invasive arterial blood pressure monitoring. The results were compelling: a mean absolute difference of only 4.38 mmHg for systolic blood pressure (SBP) and 3.93 mmHg for diastolic blood pressure (DBP).

Crucially, the device met the stringent requirements of ISO 81060-2:2018, the international standard for the clinical accuracy of non-invasive blood pressure monitors.

This level of precision is not just impressive; it's transformative. It means that patients can now monitor their blood pressure with confidence in various real-life scenarios – while relaxing on the sofa, working at a desk, or even during light activities – without the constant worry of arm positioning impacting the data.

This empowers individuals with hypertension to take a more proactive and accurate role in managing their health, providing their doctors with more reliable data for diagnosis and treatment adjustments.

BSP Inc.'s vision extends beyond mere measurement. By enabling continuous, accurate, and convenient monitoring, CART-BP Pro is set to transform the paradigm of hypertension management from reactive to proactive.

The ability to track blood pressure 24/7 opens new avenues for personalized care, early detection of issues, and more effective treatment strategies. The company is actively pursuing FDA and CE approvals, paving the way for a global rollout that will bring this life-changing technology to patients and healthcare systems worldwide.

With CART-BP Pro, Bio-Signal Platform Inc.

isn't just launching a new device; they are unveiling a new future for blood pressure management – one where accuracy, convenience, and continuous insight combine to empower healthier lives.